You are here: vision-research.eu » People » Researcher » Peto, Tunde

Tunde Peto

Short CV

Education:

  • MD and Master of Health Education: University of Szeged, Hungary
  • PhD: University of Newcastle, Australia

Current post: 

  • NIHR BMRC Fellow in Ophthalmology at the Institute of Ophthalmology, University College London and Moorfields Eye 
  • Visiting Reader, University of Surrey
  • Head of Reading Centre and Medical Retina Specialist
  • Moorfields Eye Hospital NHS Foundation Trust
  • Member of BMRC 
  • Clinical Lead of the Tower Hamlets PCT Diabetic Retinopathy Screening Service, Diabetes Centre, Mile End Hospital

Documents

CV of Tunde Peto [pdf]

Scientifc Interest

  • Imaging
  • Diabetes
  • Macular Telangiectasia
  • Zinc and the eye
  • Drusen formation 

Memberships

  • ARVO - Programme Board Member for CL
  • EASD
  • EASDec -Secretary
  • EVI – Head of Reading Centre Committee
Tunde Peto
Tunde Peto

Research Group

Reading Centre

[more information]

Contact

UCL Institute of Ophthalmology
Moorfields Eye Hospital NHS Foundation Trust

NIHR Biomedical Research Centre for Ophthalmology

162 City Road
London, EC1V 2PD
United Kingdom

Phone: +44 207 566 2815
Fax: +44 207 608 6925

E-mail:
Tunde.Peto[at]moorfields.nhs.uk

Website:
http://www.readingcentre.org

Key Publications

  1. Retinal crystals in type 2 idiopathic macular telangiectasia.
    Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T;
    MacTel Study Group. Ophthalmology. 2011 Dec;118(12):2461-7.
  2. Analysis of candidate genes for macular telangiectasia type 2.
    Parmalee NL, Schubert C, Merriam JE, Allikmets K, Bird AC, Gillies MC, Peto T, Figueroa M, Friedlander M, Fruttiger M, Greenwood J, Moss SE, Smith LE, Toomes C, Inglehearn CF, Allikmets R.
    Mol Vis. 2010 Dec 14;16:2718-26.
  3. The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD).
    Mann SS, Rutishauser-Arnold Y, Peto T, Jenkins SA, Leung I, Xing W, Bird AC, Bunce C, Webster AR.
    Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):209-14.
  4. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.
    Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W;
    ABC Trial Investigators. BMJ. 2010 Jun 9;340:c2459
  5. Agreement between image grading of conventional (45°) and ultra wide-angle (200°) digital images in the macula in the Reykjavik eye study.
    Csutak A, Lengyel I, Jonasson F, Leung I, Geirsdottir A, Xing W, Peto T. 
    Eye (Lond). 2010 Oct; 24(10):1568-75.
  6. Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1.
    Michaelides M, Fraser-Bell S, Hamilton R, Kaines A, Egan C, Bunce C, Peto T, Hykin P. 
    Retina. 2010 May;30(5):781-6.
  7. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
    Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG.
    Ophthalmology. 2010 Jun;117(6):1078-1086.e2.
  8. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.
    Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa MJ, Harrington MW; MacTel Research Group.
    Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):66-73.
  9. Verteporfin photodynamic therapy cohort study: report 1: effectiveness and factors influencing outcomes.
    Harding SP, Tomlin K, Reeves BC, Langham J, Walker J, Carpenter J, Grieve R, Patton WP, Muldrew KA, Peto T, Chakravarthy U; Verteporfin Photodynamic Therapy Cohort Study Group.
    Ophthalmology. 2009 Dec;116(12):e1-8.
  10. Functional aspects of drusen regression in age-related macular degeneration.
    Sallo FB, Rechtman E, Peto T, Stanescu-Segall D, Vogt G, Bird AC, Fitzke FW .
    Br J Ophthalmol. 2009 Oct;93(10):1345-50.

Research Groups

People

Missing some information on vision-research.eu?

* mandatory field